Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose escalating study of apotransferrin in atransferrinemia
2009-017409-13Phase 2Active
- Sponsor
- Sanquin Plasma Products
- Start
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of apotransferrin in Atransferrinemia, sponsored by Sanquin Plasma Products. Primary endpoints: Serum transferrin concentration, Serum ferritin concentration and 4 more. Started Jun 2010; status: active.
02
Drugs
apotransferrin
03
Conditions
Atransferrinemia
Beyond the preview
Go deeper on 2009-017409-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017409-13.